Cybin Inc. (NEO:CYBN)
Canada
· Delayed Price · Currency is CAD 11.25
-0.45 (-3.85%)
Jun 27, 2025, 3:58 PM EDT
Cybin Employees
Cybin had 50 employees as of March 31, 2024. The number of employees did not change compared to the previous year.
Employees
50
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-2.08M CAD
Market Cap
227.39M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 50 | 0 | - |
| Mar 31, 2023 | 50 | 0 | - |
| Mar 31, 2022 | 50 | 12 | 31.58% |
| Mar 31, 2021 | 38 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Sienna Senior Living | 12,263 |
| Green Thumb Industries | 4,800 |
| dentalcorp Holdings | 10,200 |
| Extendicare | 23,000 |
| Cronos Group | 459 |
| WELL Health Technologies | 1,507 |
| Trulieve Cannabis | 6,000 |
| Curaleaf Holdings | 5,519 |
Cybin News
- 15 days ago - Cybin Provides Corporate Update and Highlights Positive Regulatory Signals for Psychedelic Therapeutics - Business Wire
- 16 days ago - Cybin to Participate in the H.C. Wainwright 6th Annual Neuro Perspectives Conference - Business Wire
- 17 days ago - Cybin to Participate in the 2025 Psychedelic Science Conference - Business Wire
- 25 days ago - Cybin Announces Additional U.S. Patent Supporting its CYB004 Program in Phase 2 Development for Generalized Anxiety Disorder - Business Wire
- 5 weeks ago - Cybin to Participate in Water Tower Research Fireside Chat on May 29, 2025 - Business Wire
- 5 weeks ago - Cybin Applauds FDA Commissioner Dr. Martin Makary's Call to Accelerate and Prioritize Research on Psychedelic Therapeutics - Business Wire
- 6 weeks ago - Cybin taps Thermo Fisher for potential commercial manufacturing of CYB003 - Seeking Alpha
- 6 weeks ago - Cybin Engages Thermo Fisher Scientific to Provide U.S.-Based Manufacturing for its CYB003 Program for the Adjunctive Treatment of Major Depressive Disorder - Business Wire